Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of β-amyloid (Aβ) in the brains of animal models for Alzheimer’s disease, but also results in a substantial improvement in memory deficit…. Read the full story from the UCSD Newsroom

Dr. Vivian Y. H. Hook

The study’s lead investigator is Vivian Y. H. Hook, PhD (pictured above left), professor in the departments of neurosciences and pharmacology and Professor of Medicine in the Division of Nephrology-Hypertension.

Read the abstract of the study published online in the Journal of Alzheimer’s Disease.

%d bloggers like this: